M&T Bank
ARNA

M&T Bank’s Arena Pharmaceuticals Inc ARNA Stock Holding History

M&T Bank’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-1,232
Closed -$57K – 2076
2015
Q2 		$57K Sell
1,232
-352
-22% -$15.3K ﹤0.01% 1931
2015
Q1 		$69K Sell
1,584
-349
-18% -$16.2K ﹤0.01% 1876
2014
Q4 		$67K Sell
1,933
-809
-30% -$32.8K ﹤0.01% 1904
2014
Q3 		$115K Buy
+2,742
New +$122K ﹤0.01% 1999

Other funds holding ARNA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

M&T Bank's ARNA Position: Q3 2015 in Review

M&T Bank sold out of Arena Pharmaceuticals Inc (ARNA) in Q3 2015, closing a stake of 1,232 shares — an estimated $57K sold.

M&T Bank first reported a position in ARNA in Q3 2014 and held it in 4 quarters. The position peaked at $115K in Q3 2014. 120 funds tracked by Wall St. Rank hold ARNA as of Q3 2015.

  • M&T Bank reported no remaining Arena Pharmaceuticals Inc position as of Q3 2015 after selling out during the quarter.
  • M&T Bank sold 1,232 Arena Pharmaceuticals Inc shares in Q3 2015, an estimated $57K.
  • M&T Bank first reported a position in Arena Pharmaceuticals Inc in Q3 2014 and held it in 4 quarters.
  • M&T Bank's Arena Pharmaceuticals Inc position peaked at $115K in Q3 2014.
  • 120 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q3 2015.

Based on M&T Bank's 13F filing for Q3 2015, filed 13 Nov 2015.